Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01669798
Title BIBF 1120 in Bevacizumab Resistant, Persistent, or Recurrent Epithelial Ovarian Cancer
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors AA Secord
Indications

ovarian carcinoma

peritoneal carcinoma

fallopian tube carcinoma

malignant ovarian Brenner tumor

Therapies

Nintedanib

Age Groups: adult
Covered Countries USA


No variant requirements are available.